NCT02055456View on ClinicalTrials.gov

Nandrolone Decanoate in the Treatment of Telomeropathies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Aplastic AnemiaBone Marrow Failure SyndromesIdiopathic Pulmonary FibrosisTelomere Shortening
Interventions
DRUG

Nandrolone Decanoate

Trial Locations (1)

14048-900

Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirão Preto

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT02055456 - Nandrolone Decanoate in the Treatment of Telomeropathies | Biotech Hunter | Biotech Hunter